Proclaim is now approved for patients with painful diabetic peripheral neuropathy, Abbott said in a Jan. 26 news release. The SCS system also connects to the Abbott’s NeuroSphere virtual clinic, which allows for remote communication with physicians.
Abbott’s Proclaim SCS was approved for chronic pain treatment in 2019.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
